Osiris Therapeutics' Stock Is Higher On Tuesday: Here's Why


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


Shares Of Osiris Therapeutics, Inc. (NASDAQ: OSIR), a medical products company that focuses on regenerative medicine, traded higher by nearly 4 percent at $10.41 on Tuesday following a business update.Osiris announced that a medicare contractor, Cahaba Government Benefit Administrations, confirmed that Grafix has been approved for coverage with patients that suffer from chronic wounds.Osiris continued that coverage for Grafix became effective as of January 1, 2016 and covers 3.8 million lives across Alabama, Georgia and Tennessee. In total, Grafix is now available to 135 million Medicare, Medicaid and commercial beneficiaries. Osiris also stated that Grafix has been awarded a contract with a major Group Purchasing Organization (GPO) that has over 1600 members nationwide.

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: NewsCahaba Government Benefit AdministrationsGrafixmedicareOsiris Therapeutics